Financials Shanghai Titan Scientific Co., Ltd.

Equities

688133

CNE100005XG3

Specialty Chemicals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
28.27 ^CNY	+1.91%		-3.18%	-39.01%

Apr. 29	Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 21	Shanghai Titan Scientific Co., Ltd. agreed to acquire 30% stake in Shanghai Magal Scientific Instrument Co., Ltd. from Wu Gang and Ling Hui.	CI

Valuation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	10,197	16,638	11,641	5,468	3,335	-	-
Enterprise Value (EV) ¹	10,197	16,638	11,641	5,468	3,335	3,335	3,335
P/E ratio	78.7 x	115 x	87.6 x	74.8 x	33.1 x	12.7 x	20.6 x
Yield	-	-	0.14%	0.22%	0.39%	0.58%	-
Capitalization / Revenue	7.37 x	7.69 x	4.46 x	1.97 x	1.05 x	0.79 x	0.9 x
EV / Revenue	7.37 x	7.69 x	4.46 x	1.97 x	1.05 x	0.79 x	0.9 x
EV / EBITDA	79.8 x	86.4 x	62.7 x	40.4 x	14.1 x	10.7 x	9.74 x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Price to Book	7.09 x	10.6 x	4.28 x	1.96 x	1.16 x	1.09 x	1.07 x
Nbr of stocks (in thousands)	106,749	106,749	117,700	117,969	117,969	-	-
Reference price ²	95.52	155.9	98.91	46.35	28.27	28.27	28.27
Announcement Date	2/25/21	2/25/22	2/27/23	2/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,384	2,164	2,608	2,771	3,191	4,204	3,717
EBITDA ¹	127.7	192.6	185.6	135.3	236	311.7	342.5
EBIT ¹	112.6	170.7	151.7	86.36	119.1	196.5	190.1
Operating Margin	8.13%	7.89%	5.82%	3.12%	3.73%	4.67%	5.11%
Earnings before Tax (EBT) ¹	117.4	169.7	151.1	86.09	119	196.4	189.7
Net income ¹	102.8	144	124.8	72.76	100.3	224.6	161.6
Net margin	7.42%	6.65%	4.79%	2.63%	3.14%	5.34%	4.35%
EPS ²	1.214	1.350	1.129	0.6200	0.8533	2.218	1.370
Free Cash Flow	-	-	-	-	-	-	-
FCF margin	-	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-
Dividend per Share ²	-	-	0.1429	0.1000	0.1100	0.1650	-
Announcement Date	2/25/21	2/25/22	2/27/23	2/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2022 Q1
Net sales	-
EBITDA	-
EBIT	-
Operating Margin	-
Earnings before Tax (EBT)	-
Net income ¹	19.43
Net margin	-
EPS	-
Dividend per Share	-
Announcement Date	4/27/22

¹CNY in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-	-
ROE (net income / shareholders' equity)	13.8%	9.53%	6.35%	2.64%	3.5%	6.86%	5.31%
ROA (Net income/ Total Assets)	-	-	3.8%	-	2.3%	3.8%	-
Assets ¹	-	-	3,282	-	4,359	5,910	-
Book Value Per Share ²	13.50	14.80	23.10	23.70	24.30	25.90	26.40
Cash Flow per Share ²	-1.290	-2.270	-1.290	-1.060	-0.1800	0.5600	0.2200
Capex ¹	96.5	135	300	463	228	231	194
Capex / Sales	6.97%	6.25%	11.49%	16.7%	7.15%	5.5%	5.23%
Announcement Date	2/25/21	2/25/22	2/27/23	2/25/24	-	-	-

¹CNY in Million²CNY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shanghai Titan Scientific Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

28.27 CNY

Average target price

36.87 CNY

Spread / Average Target

+30.41%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
SHANGHAI TITAN SCIENTIFIC CO., LTD.	-39.01%	462M
ECOLAB INC.	+17.80%	66.73B
SIKA AG	+2.92%	49.79B
GIVAUDAN SA	+19.98%	42.5B
FUJIFILM HOLDINGS CORPORATION	+21.94%	26.45B
EMS-CHEMIE HOLDING AG	+12.04%	19.66B
CELANESE CORPORATION	+1.27%	17.18B
POSCO FUTURE M CO., LTD.	-22.98%	15.82B
SYMRISE AG	+2.77%	15.56B
ALBEMARLE CORPORATION	-9.25%	15.41B

Other Specialty Chemicals